Honestly, it's frustrating to see Australia clinging to protectionist policies when open markets benefit everyone in the long run. If the U.S. wants fair access for pharmaceuticals and tech, that’s not unreasonable—it’s about leveling the playing field. Trade barriers like these just stifle innovation and drive up costs for consumers. Australia should be thinking about long-term economic growth, not pandering to outdated regulatory models.